Related Experiment Video
Updated: Mar 19, 2026
08:07
Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
Published on: February 17, 2016
78.4K
Symmetry breaking in human neuroblastoma cells
Hideki Izumi1, Yasuhiko Kaneko1
1Division of Cancer Therapeutics; Research Institute for Clinical Oncology; Saitama Cancer Center ; Saitama, Japan.
Molecular & Cellular Oncology
|June 17, 2016
Summary
Asymmetric cell division (ACD) in cancer stem cells is poorly understood. This study reveals that the oncosuppressor protein TRIM32 promotes ACD, offering new insights into cancer malignancy.
Area of Science:
- Cell Biology
- Cancer Stem Cell Biology
- Molecular Oncology
Background:
- Asymmetric cell division (ACD) is crucial for stem cell renewal and differentiation.
- ACD is a hallmark of cancer stem cells (CSCs), contributing to tumor growth and malignancy.
- The molecular regulators of ACD in CSCs remain largely unidentified.
Purpose of the Study:
- To investigate the cellular mechanisms governing symmetric and asymmetric cell divisions in cancer.
- To identify key regulators of ACD in human neuroblastoma, a model for CSCs.
- To elucidate the role of the oncosuppressor protein tripartite motif containing 32 (TRIM32) in ACD.
Main Methods:
- Utilized human neuroblastoma cell lines.
- Employed cell division assays to distinguish between symmetric and asymmetric divisions.
- Investigated the expression and function of TRIM32 in regulating cell division modes.
Main Results:
- TRIM32 was identified as a positive regulator of asymmetric cell division (ACD).
- Loss of TRIM32 function altered the balance of cell division, favoring symmetric divisions.
- TRIM32's role in ACD was demonstrated in the context of human neuroblastoma cells.
Conclusions:
- The oncosuppressor TRIM32 plays a significant role in promoting asymmetric cell division.
- Understanding TRIM32's function in ACD provides novel insights into cancer stem cell biology and malignancy.
- TRIM32 emerges as a potential therapeutic target for modulating CSC behavior.
